Pharmaceutical Commerce - January/February 2017

Drug-based therapies for opioid dependency gain acceptance and reimbursement

Interchangeability will require ‘switching studies’ and postmarketing surveillance

A manufacturer chooses Almac Group for commercializing minitablets in stickpacks

Big data company gains insights from rapid analysis of lab results

The latest in cargo theft prevention, security and law enforcement activity

Five commercial trends to watch in 2017

Resources for education about senior citizens and long-term care

More hospital, but fewer practitioner deliveries

Consortium led by Veeva will establish a non-proprietary identity and permission framework

Watch for Washington tax policy reform to affect 2017 business

Shorter elapsed time in recent years shows encouraging improvement

Meanwhile, Congress strategizes repealing Obamacare, which expanded the 340b program

Healthcare providers occupy top three slots

Only 20 new molecular entities passed muster this year, less than half of 2015’s total

New consumer-education campaign led by Alliance for Safe Online Pharmacies

A preamble for a next round of legislating drug pricing?

Just released survey details lack of consensus and difficulties with current requirements

HDA’s latest Factbook tracks temperature-controlled distribution